It’s 2026. Markets are moving fast, volatility is back in control, and headlines are changing direction by the hour. While many traders are reacting late, the prepared ones are already positioning ahead of the next move.
Abercrombie & Fitch Co. (ANF) said it expects fourth quarter earnings of $3.50 to $3.60 per share on revenue of approximately $1.66 billion. The company's previous guidance was earnings of $3.40 to $3.70 per share on revenue of $1.65 billion to $1.68 billion, and the current consensus earnings estimate is $3.55 per share on revenue of $1.66 billion for the quarter ending January 31, 2026.
Abercrombie & Fitch Co is a specialty retailer, which operates stores and direct-to-consumer operations. The Company sells products, including casual sportswear apparel, including knit and woven shirts, and graphic t-shirts.
Positive Guidance
Caris Life Sciences Sees Revenue Above Estimates
Caris Life Sciences (CAI) said it expects fourth quarter revenue of approximately $281.0 million. The current consensus revenue estimate is $204.49 million for the quarter ending December 31, 2025.
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare.
Inogen, Inc. (INGN) said it expects fourth quarter revenue of approximately $82.0 million. The current consensus revenue estimate is $91.10 million for the quarter ending December 31, 2025.
Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For decades, one type of investment was reserved for the ultra-wealthy. Then Trump signed Executive Order 14330 - and opened it to everyone. Now you can get into this boom for less than $20. See what changed >>
JPMorgan Chase is Expected to Beat Estimates
JPMorgan Chase (JPM) is confirmed to report earnings on Tuesday, January 13, 2026 at approximately 6:35 AM ET. The consensus earnings estimate is $5.01 per share on revenue of $45.65 billion, a decline of 31.8% year-over-year, and the Earnings Whisper ® number is $5.12 per share. Investors are 3.5% bullish going into the company's earnings release. Option traders are pricing in a 3.9% move on earnings and the stock has averaged a 2.4% move in recent quarters.
Abercrombie & Fitch Co. (
Caris Life Sciences (
Inogen, Inc. (
JPMorgan Chase (JPM) is confirmed to report earnings on Tuesday, January 13, 2026 at approximately 6:35 AM ET. The consensus earnings estimate is $5.01 per share on revenue of $45.65 billion, a decline of 31.8% year-over-year, and the Earnings Whisper ® number is $5.12 per share. Investors are 3.5% bullish going into the company's earnings release. Option traders are pricing in a 3.9% move on earnings and the stock has averaged a 2.4% move in recent quarters.